|
|
Prepublished online as a Blood First Edition Paper on July 24, 2003; DOI 10.1182/blood-2003-04-1086.
Submitted April 8, 2003
Accepted July 14, 2003
Transferrin receptor 1 is differentially required in lymphocyte development
Renee M Ned, Wojciech Swat, and Nancy C Andrews*
Division of Medical Sciences, Harvard Medical School, Boston, MA, USA; Division of Hematology/Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute, Boston, MA, USA; Howard Hughes Medical Institute, Boston, MA, USA
Departments of Pathology and Immunology, Washington University, St. Louis, MO, USA
* Corresponding author; email: nandrews{at}enders.tch.harvard.edu.
Transferrin receptor (TfR) facilitates cellular iron uptake by mediating endocytosis of its ligand, iron-loaded transferrin. Although TfR is widely believed to be important for iron acquisition by all mammalian cells, direct experimental evidence is lacking. We have previously shown that mouse embryos homozygous for a disrupted transferrin receptor allele (TfR-/-) die of anemia before embryonic day 12.5, although most other embryonic tissues appear to be developing normally. Here, we have investigated the importance of TfR postnatally, by using TfR-/- embryonic stem cells to produce chimeric animals. We find that TfR-/- embryonic stem cells give rise to most tissues and organs, but do not contribute to hematopoietic tissues on a wild type C57BL/6J background, indicating that both adult erythropoiesis and lymphopoiesis require TfR. On an immunodeficient RAG2-/- background, TfR-/- B cell development proceeds at least to the IgM+ stage, although there are significantly fewer IgM+ cells in peripheral lymphoid organs. Conversely, T cells lacking TfR are arrested very early in their development, at the CD4-8-3- stage. These results indicate that TfR is necessary for the normal maturation of thymocytes, but that B cell development is less severely affected by the absence of TfR.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
N. C. Andrews
Forging a field: the golden age of iron biology
Blood,
July 15, 2008;
112(2):
219 - 230.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. C. Torchia, K. Boyd, J. E. Rehg, C. Qu, and S. J. Baker
EWS/FLI-1 Induces Rapid Onset of Myeloid/Erythroid Leukemia in Mice
Mol. Cell. Biol.,
November 15, 2007;
27(22):
7918 - 7934.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Schafer, R. Kehlbach, J. Wiskirchen, R. Bantleon, J. Pintaske, B. R. Brehm, A. Gerber, H. Wolburg, C. D. Claussen, and H. Northoff
Transferrin Receptor Upregulation: In Vitro Labeling of Rat Mesenchymal Stem Cells with Superparamagnetic Iron Oxide
Radiology,
August 1, 2007;
244(2):
514 - 523.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Armstrong, O. Hughes, S. Yung, L. Hyslop, R. Stewart, I. Wappler, H. Peters, T. Walter, P. Stojkovic, J. Evans, et al.
The role of PI3K/AKT, MAPK/ERK and NF{kappa}{beta} signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis
Hum. Mol. Genet.,
June 1, 2006;
15(11):
1894 - 1913.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Wingert, A. Brownlie, J. L. Galloway, K. Dooley, P. Fraenkel, J. L. Axe, A. J. Davidson, B. Barut, L. Noriega, X. Sheng, et al.
The chianti zebrafish mutant provides a model for erythroid-specific disruption of transferrin receptor 1
Development,
December 15, 2004;
131(24):
6225 - 6235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-Y. Li, G. Ram, K. Gast, X. Chen, K. Barasch, K. Mori, K. Schmidt-Ott, J. Wang, H.-C. Kuo, C. Savage-Dunn, et al.
Detection of intracellular iron by its regulatory effect
Am J Physiol Cell Physiol,
December 1, 2004;
287(6):
C1547 - C1559.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
